<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

SR 27897 - Lintitript

產(chǎn)品貨號(hào)

Axon 1245 CAS [136381-85-6] MF C20H14ClN3O3SMW 411.86 Purity: 99% Soluble in DMSO Description Potent and selective CCK1 antagonist References Certificates Categories Extra info Gully et al. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors. Eur. J. Pharmacol. 1993, 23, 232. ? Poncelet M. Et al. Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol. 1993, 348(1), 102-107. Certificate of Analysis Material Safety Data Sheet CNS Diabetes & Metabolism Miscellaneous Pain & Inflammation CCK1 Endocrinology A6 CCK1 antagonist Chemical name {2-[4-(2-Chloro-phenyl)-thiazol-2-ylcarbamoyl]-indol-1-yl}-acetic acid Parent CAS No. [136381-85-6] Order Size Unit Price Stock 10 mg €120.00 In Stock

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

SR 27897 - Lintitript

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 1245

CAS [136381-85-6]

MF C20H14ClN3O3S
MW 411.86

Purity: 99%
Soluble in DMSO

SR 27897

Description

Potent and selective CCK1 antagonist

Gully et al. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors. Eur. J. Pharmacol. 1993, 23, 232.

Poncelet M. Et al. Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol. 1993, 348(1), 102-107.

Certificate of Analysis
Material Safety Data Sheet

CNS Diabetes & Metabolism Miscellaneous Pain & Inflammation CCK1 Endocrinology A6

CCK1 antagonist

Chemical name

{2-[4-(2-Chloro-phenyl)-thiazol-2-ylcarbamoyl]-indol-1-yl}-acetic acid

Parent CAS No.

[136381-85-6]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>